These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 10639312)

  • 21. Role of virus-specific CD4+ cytotoxic T cells in recovery from mouse hepatitis virus infection.
    Wijburg OL; Heemskerk MH; Sanders A; Boog CJ; Van Rooijen N
    Immunology; 1996 Jan; 87(1):34-41. PubMed ID: 8666433
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Virus-specific delayed-type hypersensitivity (DTH). Cells mediating lymphocytic choriomeningitis virus-specific DTH reaction in mice.
    Moskophidis D; Fang L; Gossmann J; Drjupin R; Löhler J; Bruns M; Lehmann-Grube F
    J Immunol; 1990 Mar; 144(5):1926-34. PubMed ID: 1968492
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The balance between persistent virus infection and immune cells determines demyelination.
    Rodriguez M; Pavelko KD; Njenga MK; Logan WC; Wettstein PJ
    J Immunol; 1996 Dec; 157(12):5699-709. PubMed ID: 8955224
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The impact of variation in the number of CD8(+) T-cell precursors on the outcome of virus infection.
    Ehl S; Klenerman P; Zinkernagel RM; Bocharov G
    Cell Immunol; 1998 Oct; 189(1):67-73. PubMed ID: 9758696
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protection against murine cytomegalovirus retinitis by adoptive transfer of virus-specific CD8+ T cells.
    Bigger JE; Tanigawa M; Thomas CA; Atherton SS
    Invest Ophthalmol Vis Sci; 1999 Oct; 40(11):2608-13. PubMed ID: 10509656
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Qualitative and quantitative requirements for CD4+ T cell-mediated antiviral protection.
    Maloy KJ; Burkhart C; Freer G; Rülicke T; Pircher H; Kono DH; Theofilopoulos AN; Ludewig B; Hoffmann-Rohrer U; Zinkernagel RM; Hengartner H
    J Immunol; 1999 Mar; 162(5):2867-74. PubMed ID: 10072535
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytoimmunotherapy for persistent virus infection reveals a unique clearance pattern from the central nervous system.
    Oldstone MB; Blount P; Southern PJ; Lampert PW
    Nature; 1986 May 15-21; 321(6067):239-43. PubMed ID: 3086743
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic memory T cells require costimulation for effective clearance of a persistent viral infection.
    Garidou L; Heydari S; Truong P; Brooks DG; McGavern DB
    J Virol; 2009 Sep; 83(17):8905-15. PubMed ID: 19553326
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction and maintenance of CD8+ T cells specific for persistent viruses.
    van Leeuwen EM; ten Berge IJ; van Lier RA
    Adv Exp Med Biol; 2007; 590():121-37. PubMed ID: 17191382
    [No Abstract]   [Full Text] [Related]  

  • 30. Comparison of activation versus induction of unresponsiveness of virus-specific CD4+ and CD8+ T cells upon acute versus persistent viral infection.
    Oxenius A; Zinkernagel RM; Hengartner H
    Immunity; 1998 Oct; 9(4):449-57. PubMed ID: 9806631
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exhaustion of cytotoxic T cells during adoptive immunotherapy of virus carrier mice can be prevented by B cells or CD4+ T cells.
    Hunziker L; Klenerman P; Zinkernagel RM; Ehl S
    Eur J Immunol; 2002 Feb; 32(2):374-82. PubMed ID: 11813156
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of epigenetics in the acquisition and maintenance of effector function in virus-specific CD8 T cells.
    Olson MR; Russ BE; Doherty PC; Turner SJ
    IUBMB Life; 2010 Jul; 62(7):519-26. PubMed ID: 20552633
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic modification of T-cell clones for therapy of human viral and malignant diseases.
    Greenberg PD; Finch RJ; Gavin MA; Kalos M; Lewinsohn DA; Lonergan M; Lord JD; Nelson BH; Ohlén C; Sing AP; Warren EH; Yee C; Riddell SR
    Cancer J Sci Am; 1998 May; 4 Suppl 1():S100-5. PubMed ID: 9619278
    [No Abstract]   [Full Text] [Related]  

  • 34. Murine hepatitis caused by lymphocytic choriomeningitis virus. I. The hepatic lesions.
    Löhler J; Gossmann J; Kratzberg T; Lehmann-Grube F
    Lab Invest; 1994 Feb; 70(2):263-78. PubMed ID: 8139267
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasmacytoid dendritic cells control T-cell response to chronic viral infection.
    Cervantes-Barragan L; Lewis KL; Firner S; Thiel V; Hugues S; Reith W; Ludewig B; Reizis B
    Proc Natl Acad Sci U S A; 2012 Feb; 109(8):3012-7. PubMed ID: 22315415
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Transcription Factor TCF1 Preserves the Effector Function of Exhausted CD8 T Cells During Chronic Viral Infection.
    Wang Y; Hu J; Li Y; Xiao M; Wang H; Tian Q; Li Z; Tang J; Hu L; Tan Y; Zhou X; He R; Wu Y; Ye L; Yin Z; Huang Q; Xu L
    Front Immunol; 2019; 10():169. PubMed ID: 30814995
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional restoration of exhausted CD4(+) and CD8(+) T cells in chronic viral infection by vinegar-processed flos of Daphne genkwa.
    Uyangaa E; Choi JY; Patil AM; Kim JH; Kim SB; Kim K; Ryu HW; Oh SR; Eo SK
    Comp Immunol Microbiol Infect Dis; 2015 Apr; 39():25-37. PubMed ID: 25744061
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD4+ T-cell help is required for effective CD8+ T cell-mediated resolution of acute viral hepatitis in mice.
    Trautmann T; Kozik JH; Carambia A; Richter K; Lischke T; Schwinge D; Mittrücker HW; Lohse AW; Oxenius A; Wiegard C; Herkel J
    PLoS One; 2014; 9(1):e86348. PubMed ID: 24466045
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Host mechanisms in viral hepatitis.
    Lang KS
    Dig Dis; 2010; 28(1):25-30. PubMed ID: 20460887
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Principles for adoptive T cell therapy of human viral diseases.
    Riddell SR; Greenberg PD
    Annu Rev Immunol; 1995; 13():545-86. PubMed ID: 7612234
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.